Case of cerebral venous thrombosis on a patient with background of nephrotic syndrome
- 1 Department of Respiratory Medicine, Medway Maritime Hospital, Gillingham, UK
- 2 Department of Medical Oncology, Medway Maritime Hospital, Gillingham, UK
- 3 School of Cancer & Pharmaceutical Sciences, King's College London Faculty of Life Sciences and Medicine, London, UK
- 4 Department of Radiology, Medway Maritime Hospital, Gillingham, UK
- 5 Intensive Care Unit, Medway Maritime Hospital, Gillingham, UK
- 6 Faculty of Life Sciences, King's College London, London, UK
- Correspondence to Dr Antonios Revythis; antoinerevithis@hotmail.com
Abstract
Hypercoagulability is a well-described feature of nephrotic syndrome. The risk of developing a venous thrombus is higher at the time of diagnosis or shortly after. The resulting deep vein thrombosis involves the pulmonary, the deep veins of the lower limbs and renal veins, as described in the literature. We present a case of a man in his 20s with background of nephrotic syndrome, diagnosed at an age of 3 years old, with multiple relapses and on maintenance immunosuppression which is unusual, in two respects: First, the site of thrombosis was in the cerebral venous sinus and second, the onset of the thrombotic episode was years after the initial diagnosis. This case report also focuses on the perspective of the patient, who experienced a rare complication after more than two decades of living with the condition. In a literature search with the search words of ‘nephrotic syndrome’ AND ‘cerebral venous thrombosis in adults’, written in English and published from 1970 to 2/2021, we could only find a review article including 5 cases and 10 individual case reports, of which there were only 16 number of cerebral sinus venous thrombosis reported.
Background
Nephrotic syndrome is a rare disease, with an incidence of about 3 per 100 000 children per year.1 It is usually diagnosed in children, but can affect adolescents and young adults. It is usually classified in idiopathic nephrotic syndrome, where biopsy findings are usually suggestive of minimal changes, focal segmental glomerulosclerosis or mesangial proliferation.2 These are further classified in steroid responsive and steroid resistant forms.3 The other category is secondary nephrotic syndrome, which is usually secondary to systemic diseases, such as systemic lupus erythematosus, hepatitis B infection, postinfectious glomerulonephritis or vasculitides. According to the International Pediatric Nephrology Association guidelines,4 the definition of nephrotic syndrome in children is by gross proteinuria, urinary albumin: creatinine ratio ≥200 mg/mmol, 3+ on urine dipstick with associated hypoalbuminaemia (<30 g/L) or oedema. It is also suggested that urine dipstick can be used for screening at home to monitor proteinuria and then move on to suggest treatment option for both steroid responsive and non-responsive patients. Two uncommon complications associated with nephrotic syndrome are bacterial and viral infections5 and thromboembolic events, which can be potentially debilitating.6 We want to present a case with a rare complication of nephrotic syndrome, a thromboembolic event in the sagittal sinus. The uncommon site of thromboembolism coupled with the long period from diagnosis to having this complication make our case unique. We also believe that the non specific presentation and outcome provides an important learning point for the doctors in the front line. The fact that the patient responded to direct oral anticoagulants, instead of heparinoids or warfarin, may also be the starting point of further research in management of thromboembolism in unique situations.
Case presentation
A man in his 20s with long-standing nephrotic syndrome, which he was used to self-manage with short courses of corticosteroids, presented with 3 weeks of being generally unwell and with periorbital and leg oedema, when the symptoms failed to settle with the usual corticosteroid therapy. Additionally, he developed a headache with vomiting and an episode of light-headedness 2 days before the admission. He also had occasional visual blurring. He did not have any other medical history and was a non-smoker, with no history of excessive alcohol intake. His medication history included Mycophenolate mofetil as immunosuppression to prevent relapses, and prednisolone prescription on a weaning regime to use when he had a relapse. He did not take any other prescribed or over the counter medication. Importantly, there were no medication adherence concerns.
On admission to hospital, relapse of nephrotic syndrome was confirmed with high proteinuria on urianalysis with evidence of microscopic haematuria. He had pitting oedema of his lower extremities and periorbital oedema. His Glasgow Coma Score (GCS) was 15. The tone, reflexes and power on all peripheral extremities were normal. There was no abnormality in cranial nerve examination, although visual acuity was not checked. His plantar reflexes were normal, and he had normal coordination and sensation. His cardiovascular and respiratory examination was also normal. His initial observations were normal, with oxygen saturations of 98%, blood pressure of 116/82 mm Hg and heart rate of 71 beats per minute. Opthalmological examination which showed flame haemorrhages of his left retina suggestive of subhyaloid haemorrhages.
Investigations
His initial blood tests showed normal kidney function, urea and electrolytes, elevated neutrophils to 13.6×1000/cmm, haemoglobin of 175 g/L, C reactive protein of 3.7 mg/L and cholesterol of 10.8 mmol/L. Significant hyponatraemia developed during his admission of sodium 116 mEq/L without any new neurological signs. In view of the significant headache with nausea, vomiting and syncope, an urgent CT of his brain was requested. This showed hyperdense superior sagittal sinus cortical vein (figures 1 and 2). A contrast CT of his head was subsequently performed that confirmed a superior sagittal sinus thrombosis (figures 3 and 4). A MR venography was also performed (figure 5). After hyponatraemia developed, thyroid function tests were done that showed subclinical hypothyroidism. His urine sodium was <10 mEq/L, serum osmolality of 284 mOsmol/kg and urine osmolality was 793 mOsm/kg. His serum albumin was 23 g/L at presentation.
Axial non-contrast CT showing hyperintensity within superior sagittal sinus.
Sagittal non contrast CT showing hyperintensity within superior sagittal sinus.
Axial contrast CT showing absent flow in superior sagittal sinus, empty delta sign.
Sagittal contrast CT showing absent flow in superior sagittal sinus.
MR venography showing absent flow in superior sagittal sinus.
Differential diagnosis
When reviewing a young adult with headache, visual symptoms and nausea, the initial differentials should include migraine, infective causes like meningitis or encephalitis, intracranial neoplasm and idiopathic intracranial hypertension. There was no history of headache and nausea in this male and therefore migraine was highly unlikely to have an onset at this age. Especially the symptoms occurring at a time when nephrotic features were active suggestive of a different aetiology. Additionally, the pain was bilateral and the headache was gradual in onset lasting for over a week, contrary to migraine. The visual symptoms could be explained due to oedema of the optic disc or cranial nerve IV palsy. Usual culprits are mass lesions, potentially causing shift of the midline. Brain neoplasm, either primary or metastatic would be unlikely in a man in his 20s without any predisposing factors, but should be ruled out. Mass lesions of infective origin such as a cerebral abscess would also be plausible. In terms of infective causes for his symptoms, meningitis or encephalitis could present with findings of intracranial hypertension or altered consciousness. The reason for the infective causes to be high in the differential list is due to his inherent risk of bacterial infections due to the nephrotic syndrome and also due to mycophenolate mofetil. Finally, idiopathic intracranial hypertension classically tends to present with positional headache, worse in incumbency and in early morning. It should be included in the list of differentials, as it is a recognised cause of intracranial hypertension in young adults and otherwise could explain the headache and the visual symptoms.7 Intracranial hypertension can be caused by venous sinus thrombosis, which, as a rare entity was unlikely cause of this finding, at least initially. A vascular event, such as a haemorrhagic or an ischaemic stroke involving the occipital lobe would also need to be considered in the absence of visual symptoms. An ischaemic cause, however, would be quite rare in a young adult without any underlying clotting abnormalities, or rare diseases such as cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) or Fabry’s disease.8 Most of the potential differential diagnoses would require an urgent imaging and this is what pointed the clinicians to the eventual diagnosis, as mentioned above. Hyponatraemia is a common presentation in the acute medical setting and thoroughly described. The presence of peripheral overload, would be in keeping with a hypervolaemic hyponatraemia. The hyponatraemia in the presence of nephrotic syndrome can be explained due to the low intravascular blood volume resulting from the reduced oncotic pressure of low serum albumin. This stimulates the vasopressin secretion which drives the hyponatraemia.9 The high urine osmolality in our patient would be in accordance with the hyperproteinuria and the increased vasopressin that he was suffering due to the nephrotic syndrome. The low normal serum osmolality could be explained by the hyperlipidaemia, which is classically associated with nephrotic syndrome.
Treatment
He was treated initially with high dose of corticosteroids for nephrotic syndrome, and symptomatic management was initiated with antiemetics and analgesics. Following the suspicion of cerebral sinus thrombosis on the CT head, dalteparin was initiated at a therapeutic dose, according to his weight. At the onset of the significant acute hyponatraemia, he was treated initially with hypertonic sodium chloride solution in critical care. Prior to his discharge his anticoagulation was altered to the direct oral anticoagulant apixaban. His subhyaloid haemorrhages were treated conservatively with weekly monitoring.
Outcome and follow-up
He made a good recovery in the subsequent days and his oedema subsided. In terms of the presenting symptoms, his nausea and headache resolved, and his vision gradually improved. He was started on long-term anticoagulation and was followed up as an outpatient by nephrology, ophthalmology and haematology. Ophthalmology follow-up was organised weekly, nephrology follow-up was arranged as routine within 1 month for repeat protein/creatinine ratio.
The man presented again to the hospital with recurrent headache 1 week after discharge. No abnormality was found on this occasion in blood tests and clinical examination. He underwent repeat imaging of his head (magnetic resonance venography) that showed improvement with partial resolution in the previously seen thrombus. He was discharged with follow-up as mentioned before. Following a review of his nephrologist and haematologist it was agreed to commence on prophylactic anticoagulation with low dose rivaroxaban during his relapses. His follow-up imaging on 8 months showed resolution of the thrombus, within superior sagital sinus with CT of the brain (figures 6 and 7) and MRI with venogram (figure 8).
Follow-up axial non-contrast CT showing normal superior sagittal sinus.
Follow-up sagittal non-contrast CT showing normal superior sagittal sinus.
Follow-up axial MR venography showing normal superior sagittal sinus.
Discussion
Hypercoagulability in nephrotic syndrome is a known risk, involving more commonly the deep veins of the legs and the renal veins.1 A number of possible reasons have been suggested, such as loss of anticoagulation factors (plasminogen, antithrombin 3, protein C and S) an increase in production of coagulation factors (factor 5, combine factor 7, 10 and fibrinogen), hypercholesterolaemia, thrombocytosis and platelet hyperactivity.1 6 10–12 In the literature review of articles written in English, published in peer reviewed journals in PubMed by January 2021, there was a review of five similar cases. The age range of the patients in that review was 16–49, diagnosed between 2009 and 2015. The presenting complaint was headache and in two of them the cerebral venous thrombosis (CVT) was coinciding with a nephrotic syndrome relapse. It concluded that in patients with a background of nephrotic syndrome, a presentation of unexplained headaches, seizures or other neurological findings should raise suspicion of CVT.13 In the literature search we performed, cerebral sinus thrombosis was seen in children or following a recent diagnosis of nephrotic syndrome.14 15 In a series of case reports published in 1999,16 two cases of CVT were described, that presented with persistent headache, hemiparesis and seizure. In the first, the diagnosis of CVT coincided with the diagnosis of chronic tubulointerstitial nephritis, based on biopsy with recent onset of symptoms. On the second, a 16-year-old girl with a diagnosis of nephrotic syndrome in the preceding 7 months, but without any clinical evidence of decompensation, presented with headache, nausea and vomiting with an episode of seizure. Both cases showed reduced protein S levels, suggestive of acquired protein S deficiency. In another case report,17 a 53-year-old woman with recent diagnosis of nephrotic syndrome on background of alcohol associated liver cirrhosis and HBV carrier, with biopsy proved focal segmental glomerulonephritis, presented with sudden onset weakness, dysarthria and visual disturbance, with concomitant headache. This was proved to be a recent infarction in the right middle cerebral artery territory and the head of the caudate nucleus, without a signal intensity in the right internal carotid artery. This was associated with evidence of a flare up of nephrotic syndrome on urine protein and lipid profile. She was also managed with steroids and anticoagulation, with some residual weakness on follow-up, but no relapses seen on follow-up. Another case report published in 201518 mentioned that the only clinical symptom was headache and on biochemical analysis, there was evidence of reduced protein, without any clinical evidence of flare up of nephrotic syndrome. He was treated with intravenous and later oral anticoagulation, even though it was not described whether it was vitamin K inhibitors. In the case reports studied, treatment was mainly with oral anticoagulation. Either initially or after parenteral administration. The usual treatment suggested is vitamin K inhibitors, such as warfarin. Our patient was unique from the point of view of the long duration from his initial diagnosis to this current presentation. In our case it was decided that the patient can be started on direct oral anticoagulants, after initial treatment with subcutaneous low molecular weight heparin. This is an area that can be further explored. There has been an incidence of administration of edoxaban in a patient with a pulmonary embolism after anticoagulation with warfarin, with an effective outcome.19 This has been shown in our patient as well.
Patient’s perspective
‘Initially, I thought it was a flare of my nephrotic syndrome, therefore I started to take steroids that usually help. However, this time they did not. The swelling did not improve and the urine strip tests I did, showed that the protein in my urine was not reducing. Then I started having the headaches, which was unusual. This got gradually worse and they were really bad before admission. When the doctors did the scan and told me there was a clot in the brain I felt really scared. This was very surprising to me as I never thought this was a possibility. I was afraid that the clot might spread.’ When the patient was asked if he looked it up on the internet, he explained that he did not because he did not want to scare himself more.
‘Then I was told that I need to take blood thinners. I thought that it would be for a couple of weeks. Then I was surprised to find out that it was for life.’
‘Before this happened I was quite confident because I was diagnosed with the nephrotic syndrome since I was very young. I have learnt to live with it and occasionally adjust my life because of it. This event was a very shocking experience. However, I did not lose my confidence that everything will improve.’
When the patient was asked about the future, he replied that he feels positive and a similar event is not going to happen again. Overall he believes that this was a shocking and frightening experience. However, having the diagnosis of nephrotic syndrome, he has the mindset of being positive and going day-by-day with the hope that it will all go away sometime.
Learning points
-
Neurological symptoms, especially headache and vomiting, in patients with nephrotic syndrome should raise suspicion of cerebral thromboembolism. This could be venous or arterial. The variety of symptoms can be broad and also involve seizures or focal neurologic defects and visual disturbances. Headache seems to be a universal symptom under these circumstances. This is particularly important for the front door clinicians, so that they are alert to the rare causes of headaches and prompt appropriate investigations. This would eventually result in prompt diagnosis and treatment, before more debilitating symptoms occur.
-
Cerebral thromboembolism in nephrotic syndrome can manifest more commonly in children as well as young adults. Although venous thromboembolism usually occur in the first months from diagnosis, it can also manifest at a later date.
-
Patient education is important and perhaps this particular issue should be discussed as potential red flag signs.
-
Anticoagulation is traditionally with vitamin K antagonists. However, direct oral anticoagulants may also be a viable alternative.
-
We believe that our case is unique because of the long interval from diagnosis of nephrotic syndrome and cerebral venous thrombosis, with the subhyaloid haemorrhage, which may or may not be related.
Ethics statements
Patient consent for publication
Footnotes
-
Contributors AR was involved in planning, literature search, consent process, writing up the paper. SB was involved in literature review and editing. VG contributed in finding the relevant imaging needed. RS contributed in the conseption of the paper, planning, editing and overseeing the work.
-
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
-
Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.
-
Competing interests None declared.
-
Provenance and peer review Not commissioned; externally peer reviewed.
- © BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.
References
Use of this content is subject to our disclaimer